These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 23526099

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Interferon-gamma improves splicing efficiency of CYBB gene transcripts in an interferon-responsive variant of chronic granulomatous disease due to a splice site consensus region mutation.
    Condino-Neto A, Newburger PE.
    Blood; 2000 Jun 01; 95(11):3548-54. PubMed ID: 10828042
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dose-dependent enhancements by interferon-gamma on functional responses of neutrophils from chronic granulomatous disease patients.
    Ahlin A, Elinder G, Palmblad J.
    Blood; 1997 May 01; 89(9):3396-401. PubMed ID: 9129047
    [Abstract] [Full Text] [Related]

  • 6. Chronic Granulomatous Disease and Myelodysplastic Syndrome in a Patient with a Novel Mutation in CYBB.
    Reis BCS, Cunha DP, Bueno APS, Carvalho FAA, Dutra J, Mello FV, Ribeiro MCM, Milito CB, da Costa ES, Vasconcelos Z.
    Genes (Basel); 2021 Sep 23; 12(10):. PubMed ID: 34680870
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Chronic granulomatous disease in Morocco: genetic, immunological, and clinical features of 12 patients from 10 kindreds.
    Baba LA, Ailal F, El Hafidi N, Hubeau M, Jabot-Hanin F, Benajiba N, Aadam Z, Conti F, Deswarte C, Jeddane L, Aglaguel A, El Maataoui O, Tissent A, Mahraoui C, Najib J, Martinez-Barricarte R, Abel L, Habti N, Saile R, Casanova JL, Bustamante J, Salih Alj H, Bousfiha AA.
    J Clin Immunol; 2014 May 23; 34(4):452-8. PubMed ID: 24596025
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Resistant invasive aspergillosis in an autosomal recessive chronic granulomatous disease.
    Sfaihi L, Maaloul I, Fourati H, Stasia MJ, Mnif Z, Hachicha M.
    Fetal Pediatr Pathol; 2013 Jul 23; 32(4):241-5. PubMed ID: 23002911
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.
    Okura Y, Yamada M, Kuribayashi F, Kobayashi I, Ariga T.
    J Clin Immunol; 2015 Feb 23; 35(2):158-67. PubMed ID: 25666294
    [Abstract] [Full Text] [Related]

  • 16. Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.
    Ezekowitz RA, Orkin SH, Newburger PE.
    J Clin Invest; 1987 Oct 23; 80(4):1009-16. PubMed ID: 2821069
    [Abstract] [Full Text] [Related]

  • 17. A novel point mutation in the CYBB gene promoter leading to a rare X minus chronic granulomatous disease variant--impact on the microbicidal activity of neutrophils.
    Defendi F, Decleva E, Martel C, Dri P, Stasia MJ.
    Biochim Biophys Acta; 2009 Mar 23; 1792(3):201-10. PubMed ID: 19708127
    [Abstract] [Full Text] [Related]

  • 18. Activation of cryptic splice sites in three patients with chronic granulomatous disease.
    de Boer M, van Leeuwen K, Hauri-Hohl M, Roos D.
    Mol Genet Genomic Med; 2019 Sep 23; 7(9):e854. PubMed ID: 31364312
    [Abstract] [Full Text] [Related]

  • 19. CRISPR-gene-engineered CYBB knock-out PLB-985 cells, a useful model to study functional impact of X-linked chronic granulomatous disease mutations: application to the G412E X91+-CGD mutation.
    Beaumel S, Verbrugge L, Fieschi F, Stasia MJ.
    Clin Exp Immunol; 2023 Apr 25; 212(2):156-165. PubMed ID: 36827093
    [Abstract] [Full Text] [Related]

  • 20. Clinical evaluation of interferon-gamma treatment to chronic granulomatous disease patients with splice site mutations.
    Nunoi H, Ishibashi F, Mizukami T, Hidaka F.
    Jpn J Infect Dis; 2004 Oct 25; 57(5):S25-6. PubMed ID: 15507763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.